Patients who feel low when having a cardiac device implanted are more likely to stop taking their heart medications than those without depression, according to research presented today at ACNAP 2023, a scientific congress of the European Society of Cardiology.
MarketingRx roundup: Viatris taps former Moderna exec for commercial chief; Merck debuts PAH effort
New commercial chief at Viatris: Viatris named Corinne Le Goff as its new chief commercial officer on Monday. Le Goff comes from Imunon where she